Ella Instrument- Automated Immunoassay Machine acquisition

Background
The Translational Neuroradiology Section (TNS) of the National Institute of Neurological Disorders and Stroke (NINDS) is focused on elucidating the mechanisms by which multiple sclerosis (MS) and related neuroinflammatory pathologies impact the central nervous system (CNS).

The goal of this contract is to acquire the Ella Immunoassay System (Bio-Techne), which is essential for high-throughput, high-sensitivity technologies necessary for comprehensive immune profiling and biomarker quantification in ongoing investigations related to MS.

Work Details
The contract involves the acquisition of the Ella Automated Immunoassay System from Bio-Techne, catalog #600-100. The system is designed for multiplexed, protein-based analysis of serum and plasma samples with minimal sample volume requirements.

Key specifications include:
- ELISA workflow immunoassay
- All-in-one desktop computer with Windows operating system
- Simple Plex Runner and Explorer software
- 1 verification cartridge included
- Results in less than 90 minutes
- High reproducibility and automated biomarker detection
- 4+ logs of dynamic range
- Benchtop design requiring just 25 µL of sample
- Eliminates cross-reactivity by detecting each analyte in separate parallel channels
- Short hands-on prep time with zero pipetting error
- Consistency in results guaranteed
- One year warranty and training included
- Simple Plex demo kit cartridge provided.

Period of Performance
The geographic location(s) the product will be delivered to or performed at

Bidder Requirements
Bidders must be authorized distributors or manufacturers of the Ella Immunoassay System. No specific country-of-origin restrictions were mentioned.